Search

everythinglearnresearchcommunity

for

Search:↓

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Pentoxifylline helps hair regrowth in rats with hair loss.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

PPX causes much less hair loss than traditional taxanes.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tocilizumab might be an effective treatment for COVID-19.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.